Finally, a set of 11 genes were identified as candidate biomarkers for differentiating between tumor and normal groups among the 8863 DEGs, including STX12, PHF14, ECT2, PRIM2, CENPL, CTHRC1, INHBA, RNFT2, CLSPN, ESM1, and COL10A1. This evidence concerns the gene RNFT2 and neoplasm.